-+ 0.00%
-+ 0.00%
-+ 0.00%

Purple Biotech Q3 EPS $(0.60) Beats $(2.88) Estimate

Benzinga·11/17/2026 13:05:53
语音播报
Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(2.88) by 79.17 percent. This is a 79.02 percent increase over losses of $(2.86) per share from the same period last year.